Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient.
about
The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosisAgeing and Parkinson's disease: why is advancing age the biggest risk factor?Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.Alpha-synuclein and tau: teammates in neurodegeneration?Evaluation of alpha-synuclein immunohistochemical methods used by invited expertsAlzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.Novel antibody capture assay for paraffin-embedded tissue detects wide-ranging amyloid beta and paired helical filament-tau accumulation in cognitively normal older adults.GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.Blood pressure and brain injury in older adults: findings from a community-based autopsy study.Association between lifetime cigarette smoking and lewy body accumulation.Pathologic correlates of dementia in individuals with Lewy body disease.Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe ConsortiumNational Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's diseaseFamilial prion disease with Alzheimer disease-like tau pathology and clinical phenotype.White matter lesions defined by diffusion tensor imaging in older adultsEcology of the aging human brainNeocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-oldA Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristicsMultiple pathologies are common and related to dementia in the oldest-old: The 90+ Study.Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.APOE ε4 increases risk for dementia in pure synucleinopathies.Altered Proteins in the Aging BrainLewy body pathology in normal elderly subjects.Visual hallucinations in dementia: a prospective community-based study with autopsy.Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies.Cognitive impairment in older adults without dementia: clinical and pathologic outcomes in a community-based sampleMilestones in Parkinson's disease--clinical and pathologic features.Neuropathology underlying clinical variability in patients with synucleinopathies.Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.The Lewy body in Parkinson's disease and related neurodegenerative disorders.The function of α-synuclein.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Amygdala α-Synuclein Pathology in the Population-Based Vantaa 85+ Study.Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes.The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies.
P2860
Q27004240-5F7DAED5-7379-4C66-BD26-1F88BD92B609Q27021628-5187DD80-9ABE-4F78-910B-73E8EE471266Q27686837-860C3A43-89AA-47F3-BC41-BAE926D2E918Q28250508-1F1DB56B-3459-4F4F-BCE1-D8CF96F6ED95Q30488694-C6B9397B-CF73-4395-972F-91F5D12520B5Q30493972-B25089C2-09FE-4086-BA52-5F6561901A20Q30506492-A86298B0-8BB8-4A30-B183-50C3CD5703CDQ30527838-030C9B67-9215-4886-AF93-B43147ED3421Q33637739-3CA1773B-1E4E-4AE0-8639-55A0EBED1F15Q33829013-3400E31C-875A-4B0B-BC94-C96406C51951Q33896668-06DF6911-0120-40E6-A596-F744D4B4E9CEQ34023599-0AB74AB1-1100-48A6-B3A2-C97E053A32EEQ34635272-176D6A40-54EE-419C-94F5-B90BA25D416DQ35043994-FB6754FF-FE1B-46A7-A7F5-A185CB0A7A8FQ35224243-68335CC3-4E89-46C9-8130-A53E52A43274Q35556875-57389068-68A9-46D6-83BA-A58B95CEA8D2Q35606753-DAAB75FD-540E-4C70-91C7-0DF56D97FB05Q35924508-A0EBF084-A3F8-45D5-9CC7-B2E3C78CD166Q35966448-6FF33C70-3AA6-446B-BD76-00DA31DD6A98Q36004679-FDD8EFD0-019E-4857-969E-6417944D55ABQ36581696-94564291-EFE6-4ED8-9D52-D3377B02E363Q36634159-B5B98376-9CC4-4032-B824-C96BCC40245AQ36692073-3B5BF734-686A-47C7-9FE6-50F1615B0120Q37246606-A0ED1BFA-A69E-4FCE-A932-6BBEE8872A70Q37343136-936C9FF2-340E-4F20-8592-863A06F619A8Q37376010-E2A17E17-F3AD-41FE-9FEC-A6051D2826D0Q37393410-C5D7A245-7C48-4342-9452-88518354329BQ37438087-87ABF7C1-F925-45F6-9917-CDC82FBC4E72Q37882587-003D9EF5-8155-436F-975C-C19515AC12A0Q37896515-379C875D-46D6-43ED-A124-DB1F3EF4463EQ37955871-1D3E6AD9-01DC-48B9-86E8-341A998791D0Q38012653-53AB0D33-64B0-4D4E-ABAF-96C8992B0CBCQ38139561-BB673F17-31DB-4E6B-9C5E-721868A70AF5Q38669105-1F19146C-9C93-4039-92D8-976C6B09124AQ38797714-6C9D7FB0-F8B5-495A-A9A0-399C6B5C8F91Q38848617-CE3E0CA0-2FB9-44F0-9E1E-38C691BD17EFQ45232246-F61A7E3D-8A59-45BD-8D99-80E034C4C553Q46251905-4D70622F-CFE0-4CD1-9F2E-E44FACF776A8Q48287129-29402D54-F81B-4F50-9D12-85AEC9B7118CQ48575031-075F2E6D-C023-4052-B1C8-1C8FAC285DFA
P2860
Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Empiric refinement of the path ...... ology in the dementia patient.
@en
Empiric refinement of the path ...... ology in the dementia patient.
@nl
type
label
Empiric refinement of the path ...... ology in the dementia patient.
@en
Empiric refinement of the path ...... ology in the dementia patient.
@nl
prefLabel
Empiric refinement of the path ...... ology in the dementia patient.
@en
Empiric refinement of the path ...... ology in the dementia patient.
@nl
P2093
P2860
P50
P921
P1433
P1476
Empiric refinement of the path ...... ology in the dementia patient.
@en
P2093
Aimee Schantz
Christopher Clark
Darcy Vavrek
Douglas Galasko
Eric B Larson
Oscar Lopez
Ronald Hamilton
Thomas J Montine
P2860
P304
P356
10.1111/J.1750-3639.2007.00117.X
P50
P577
2008-01-29T00:00:00Z